These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12718851)

  • 1. Finding the intracellular signaling pathways affected by mood disorder treatments.
    Coyle JT; Duman RS
    Neuron; 2003 Apr; 38(2):157-60. PubMed ID: 12718851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.
    Chen G; Hasanat KA; Bebchuk JM; Moore GJ; Glitz D; Manji HK
    Psychosom Med; 1999; 61(5):599-617. PubMed ID: 10511011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
    Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
    Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?
    Abrial E; Lucas G; Scarna H; Haddjeri N; Lambás-Señas L
    Mol Neurobiol; 2011 Dec; 44(3):407-19. PubMed ID: 21983961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
    Chen G; Manji HK
    Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.
    Chen G; Huang LD; Zeng WZ; K Manji H
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):47-64. PubMed ID: 11343630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers.
    Kim EJ; Lee DK; Hong SG; Han J; Kang D
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism and clinical effects of drugs for mood disorder].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):358-61. PubMed ID: 12877002
    [No Abstract]   [Full Text] [Related]  

  • 12. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel drugs and therapeutic targets for severe mood disorders.
    Mathew SJ; Manji HK; Charney DS
    Neuropsychopharmacology; 2008 Aug; 33(9):2080-92. PubMed ID: 18172433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder.
    Xie X; Hagan RM
    Neuropsychobiology; 1998 Oct; 38(3):119-30. PubMed ID: 9778599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder.
    Schloesser RJ; Huang J; Klein PS; Manji HK
    Neuropsychopharmacology; 2008 Jan; 33(1):110-33. PubMed ID: 17912251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological brain changes in depression: can antidepressants reverse them?
    Miguel-Hidalgo JJ; Rajkowska G
    CNS Drugs; 2002; 16(6):361-72. PubMed ID: 12027783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of brain-derived neurotrophic factor in mood disorders.
    Hashimoto K; Shimizu E; Iyo M
    Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal plasticity and survival in mood disorders.
    Duman RS; Malberg J; Nakagawa S; D'Sa C
    Biol Psychiatry; 2000 Oct; 48(8):732-9. PubMed ID: 11063970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
    Gray NA; Zhou R; Du J; Moore GJ; Manji HK
    J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics.
    Pisanu C; Papadima EM; Del Zompo M; Squassina A
    Neurosci Lett; 2018 Mar; 669():24-31. PubMed ID: 27343410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.